IL6 and neoplasm: Furthermore, GTN lowers the levels of IL‐6, IL‐17, and TNF‐α in tumor tissue and prevents the activation of stromal immune cells and the nuclear translocation of NF‐κB (Vendramini‐Costa et al. 2017).